RXI Pharma (RXII) Tops Q1 EPS by 11c
Get Alerts RXII Hot Sheet
Join SI Premium – FREE
RXI Pharma (NASDAQ: RXII) reported Q1 EPS of ($0.34), $0.11 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $10 million, versus $34 million reported last year.
For earnings history and earnings-related data on RXI Pharma (RXII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
- Mannatech (MTEX) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share